Pro-tect Sports Sunscreen Lotion
NDC Package 37945-862-65
Package Information
Pro-tect Sports Sunscreen (meradimate, octinoxate, octisalate, oxybenzone) lotions is •Apply liberally and evenly on all exposed areas 20-30 minutes before exposure to the sun and as needed. This formulation utilizes a lotion delivery system. Marketed by Bio-medical & Pharmaceutical Manufacturing Corporation, this product is identified by NDC 37945-862 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
- Cutaneous - Administration to the skin.
- Cutaneous - Administration to the skin.
Regulatory & Marketing
Hierarchy Structure
- 37945 - Bio-medical & Pharmaceutical Manufacturing Corporation
- 37945-862 - Pro-tect Sports Sunscreen
- 37945-862-65 - 190 g in 1 CONTAINER
- 37945-862 - Pro-tect Sports Sunscreen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (37945-862). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 37945-862-65 identifies a specific commercial package of 190 g in 1 container of Pro-tect Sports Sunscreen, a human over the counter drug labeled by Bio-medical & Pharmaceutical Manufacturing Corporation. This lotion is formulated for cutaneous use and contains meradimate; octinoxate; octisalate; oxybenzone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bio-medical & Pharmaceutical Manufacturing Corporation on May 27, 2015. The current certification is valid through December 31, 2026.
How is this Bio-medical & Pharmaceutical Manufacturing Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 37945086265. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.